Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast CancerMariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai, et al.NPJ Breast Cancer|July 20, 2017
Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trialKerin Adelson, Bhuvaneswari Ramaswamy, Joseph A Sparano, et al.Pathology, Research and Practice|April 21, 2026
Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel eventsEda Nur Kozan, Jesús Delgado-de la Mora, Majd Al Assaad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN TrialKevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.NPJ Breast Cancer|June 25, 2019
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancerBruno V Sinn, Chunxiao Fu, Rosanna Lau, et al.The Oncologist|May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.Communications Medicine|January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohortMajd Al Assaad, Kevin Hadi, Max F Levine, et al.JAMA|May 12, 2011
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancerChristos Hatzis, Lajos Pusztai, Vicente Valero, et al.JCO Precision Oncology|October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic CancerVerena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.Pageof 5